Detalhe da pesquisa
1.
Family history in the Finnish Prostate Cancer Screening Trial.
Int J Cancer
; 136(9): 2172-7, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274038
2.
The Finnish prostate cancer screening trial: analyses on the screening failures.
Int J Cancer
; 136(10): 2437-43, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25359457
3.
Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Prostate
; 75(13): 1394-402, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26073992
4.
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.
Br J Cancer
; 113(7): 1086-93, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26291059
5.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet
; 384(9959): 2027-35, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108889
6.
Prostate-cancer mortality at 11 years of follow-up.
N Engl J Med
; 366(11): 981-90, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417251
7.
Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
BJU Int
; 112(6): 735-41, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23746332
8.
Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).
Acta Oncol
; 52(8): 1615-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23786174
9.
Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening.
Int J Cancer
; 131(6): 1367-75, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052356
10.
Screening and prostate-cancer mortality in a randomized European study.
N Engl J Med
; 360(13): 1320-8, 2009 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19297566
11.
Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screening.
Int J Cancer
; 127(7): 1699-705, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473861
12.
Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Int J Cancer
; 127(7): 1650-9, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20073066
13.
Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial.
BJU Int
; 106(4): 472-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20184578
14.
Biological aggressiveness of prostate cancer in the Finnish screening trial.
Int J Cancer
; 124(3): 547-52, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19004023
15.
Assessment of causes of death in a prostate cancer screening trial.
Int J Cancer
; 122(2): 413-7, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17935123
16.
Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.
Eur J Cancer
; 43(4): 775-81, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17251005
17.
Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Eur Urol Focus
; 3(2-3): 212-220, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28753762
18.
Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Scand J Urol
; 50(4): 267-73, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26927237
19.
Family history and prostate cancer screening with prostate-specific antigen.
J Clin Oncol
; 20(11): 2658-63, 2002 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12039927
20.
Second round results of the Finnish population-based prostate cancer screening trial.
Clin Cancer Res
; 10(7): 2231-6, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15073097